High Dose Chemotherapy Followed By PBSC Rescue for HD

Not Applicable

Completed

• Conditions: Hodgkin Disease

• Registration Number: NCT00186251
• Lead Sponsor: Stanford University

Brief Summary

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

Detailed Description

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Study Timeline

• Study Start: 1998-03
• Study Completion: 2005-07
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Status Verified: 2012-07
• Last Update Submitted: 2012-11-09
• Last Update Posted: 2012-11-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• adequate organ function

• recurrent HD

Exclusion Criteria

• CNS disease

• no prior malignancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Overall survival
FFS
Response rates

Secondary Outcome Measures

Name	Time	Method
Toxicity of high dose chemotherapy

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States